280 related articles for article (PubMed ID: 10618391)
1. Analysis of receptor signaling pathways by mass spectrometry: identification of vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors.
Pandey A; Podtelejnikov AV; Blagoev B; Bustelo XR; Mann M; Lodish HF
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):179-84. PubMed ID: 10618391
[TBL] [Abstract][Full Text] [Related]
2. Vav family proteins couple to diverse cell surface receptors.
Moores SL; Selfors LM; Fredericks J; Breit T; Fujikawa K; Alt FW; Brugge JS; Swat W
Mol Cell Biol; 2000 Sep; 20(17):6364-73. PubMed ID: 10938113
[TBL] [Abstract][Full Text] [Related]
3. In vitro phosphorylation of the epidermal growth factor receptor autophosphorylation domain by c-src: identification of phosphorylation sites and c-src SH2 domain binding sites.
Lombardo CR; Consler TG; Kassel DB
Biochemistry; 1995 Dec; 34(50):16456-66. PubMed ID: 8845374
[TBL] [Abstract][Full Text] [Related]
4. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.
O'Bryan JP; Lambert QT; Der CJ
J Biol Chem; 1998 Aug; 273(32):20431-7. PubMed ID: 9685397
[TBL] [Abstract][Full Text] [Related]
5. Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor.
Nishimura R; Li W; Kashishian A; Mondino A; Zhou M; Cooper J; Schlessinger J
Mol Cell Biol; 1993 Nov; 13(11):6889-96. PubMed ID: 7692233
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs.
Margolis B; Hu P; Katzav S; Li W; Oliver JM; Ullrich A; Weiss A; Schlessinger J
Nature; 1992 Mar; 356(6364):71-4. PubMed ID: 1531699
[TBL] [Abstract][Full Text] [Related]
7. Protein tyrosine phosphatase 1B interacts with and is tyrosine phosphorylated by the epidermal growth factor receptor.
Liu F; Chernoff J
Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):139-45. PubMed ID: 9355745
[TBL] [Abstract][Full Text] [Related]
8. Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors.
Hu P; Margolis B; Skolnik EY; Lammers R; Ullrich A; Schlessinger J
Mol Cell Biol; 1992 Mar; 12(3):981-90. PubMed ID: 1372091
[TBL] [Abstract][Full Text] [Related]
9. Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates.
Bustelo XR; Ledbetter JA; Barbacid M
Nature; 1992 Mar; 356(6364):68-71. PubMed ID: 1311423
[TBL] [Abstract][Full Text] [Related]
10. Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation.
Luttrell LM; Della Rocca GJ; van Biesen T; Luttrell DK; Lefkowitz RJ
J Biol Chem; 1997 Feb; 272(7):4637-44. PubMed ID: 9020193
[TBL] [Abstract][Full Text] [Related]
11. The tyrosine phosphatase PTP1C associates with Vav, Grb2, and mSos1 in hematopoietic cells.
Kon-Kozlowski M; Pani G; Pawson T; Siminovitch KA
J Biol Chem; 1996 Feb; 271(7):3856-62. PubMed ID: 8632004
[TBL] [Abstract][Full Text] [Related]
12. SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides.
Case RD; Piccione E; Wolf G; Benett AM; Lechleider RJ; Neel BG; Shoelson SE
J Biol Chem; 1994 Apr; 269(14):10467-74. PubMed ID: 8144631
[TBL] [Abstract][Full Text] [Related]
13. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity.
Bonita DP; Miyake S; Lupher ML; Langdon WY; Band H
Mol Cell Biol; 1997 Aug; 17(8):4597-610. PubMed ID: 9234717
[TBL] [Abstract][Full Text] [Related]
14. A new function for a phosphotyrosine phosphatase: linking GRB2-Sos to a receptor tyrosine kinase.
Li W; Nishimura R; Kashishian A; Batzer AG; Kim WJ; Cooper JA; Schlessinger J
Mol Cell Biol; 1994 Jan; 14(1):509-17. PubMed ID: 8264620
[TBL] [Abstract][Full Text] [Related]
15. Receptor-binding, tyrosine phosphorylation and chromosome localization of the mouse SH2-containing phosphotyrosine phosphatase Syp.
Feng GS; Shen R; Heng HH; Tsui LC; Kazlauskas A; Pawson T
Oncogene; 1994 Jun; 9(6):1545-50. PubMed ID: 8183548
[TBL] [Abstract][Full Text] [Related]
16. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation.
Bustelo XR; Crespo P; López-Barahona M; Gutkind JS; Barbacid M
Oncogene; 1997 Nov; 15(21):2511-20. PubMed ID: 9399639
[TBL] [Abstract][Full Text] [Related]
17. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner.
Sasaoka T; Ishihara H; Sawa T; Ishiki M; Morioka H; Imamura T; Usui I; Takata Y; Kobayashi M
J Biol Chem; 1996 Aug; 271(33):20082-7. PubMed ID: 8702728
[TBL] [Abstract][Full Text] [Related]
18. Systematic mapping of potential binding sites for Shc and Grb2 SH2 domains on insulin receptor substrate-1 and the receptors for insulin, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor.
Ward CW; Gough KH; Rashke M; Wan SS; Tribbick G; Wang J
J Biol Chem; 1996 Mar; 271(10):5603-9. PubMed ID: 8621421
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-1 induces rapid tyrosine phosphorylation of the vav proto-oncogene product.
Uddin S; Yetter A; Katzav S; Hofmann C; White MF; Platanias LC
Exp Hematol; 1996 Apr; 24(5):622-7. PubMed ID: 8605967
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine phosphorylation of Cbl upon epidermal growth factor (EGF) stimulation and its association with EGF receptor and downstream signaling proteins.
Fukazawa T; Miyake S; Band V; Band H
J Biol Chem; 1996 Jun; 271(24):14554-9. PubMed ID: 8662998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
